CVS Stock Is Soaring. A Director Bets $2 Million on the Rally.
CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
CVS’s Locked Display Fix: Trading One Type Of Friction For Another
CVS Pharmacy thinks it has found a solution to customer complaints about locked display cases - but the cure may be worse ...
Modern Healthcare2d
CVS Health, Emory expand MinuteClinic primary care services
A CVS spokesperson said the Emory collaboration is the first time MinuteClinic has expanded into primary care services in ...
BioPharma Dive2d
FTC case against PBMs can move forward, judge rules
A Missouri district court judge said stopping the FTC’s suit against Caremark, Express Scripts and Optum Rx would be “against ...
CVS names new chief executive for Caremark PBM division
In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...
Is CVS Health Corporation (CVS) the Best Performing S&P 500 Stock So Far In 2025?
We recently compiled a list of the 10 Best Performing S&P 500 Stocks So Far in 2025. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other ...